New Drug Applications Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease 4 years ago
New Drug Applications Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers 4 years ago
New Drugs FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available 4 years ago